Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EBOS Group Limited ( (AU:EBO) ) has issued an update.
EBOS Group Limited reported significant underlying growth in its half-year results for 2025, with a 9.5% increase in revenue and a 7.1% rise in underlying EBITDA, despite the loss of the CWA distribution contract. The company continues to achieve strong growth in its healthcare and animal care segments, driven by strategic acquisitions and new customer agreements, positioning itself well for sustained long-term growth.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, offering a diversified business model with strong market positions. The company is involved in community pharmacy, institutional healthcare, and branded animal care products, with a focus on growth in the Southeast Asian market.
YTD Price Performance: 11.44%
Average Trading Volume: 30,142
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$7.28B
For a thorough assessment of EBO stock, go to TipRanks’ Stock Analysis page.